2020-8-21 13:45 |
Coinspeaker Pfizer Covid-19 Vaccine Is on Track to Be Submitted for Regulatory Review in OctoberPfizer COVID-19 vaccine created in cooperation with BioNTech SE is to be submitted for review in October. origin »
|
Special thanks to the Plasma Group team for review and feedback Current approaches to layer 2 scaling - basically, Plasma and state channels - are increasingly moving from theory to practice, but at the same time it is becoming easier to see the inherent challenges in treating these techniques as a fully fledged scaling solution for Ethereum.
2019-9-2 04:03 | |
|
|
Two Ethereum Improvement Proposals (EIPs) have been approved to be included during Ethereum’s next majorupgrade scheduled for October, CoinDesk reports. The two nodes are the first to be officially endorsed among the 28 EIPs that have been submitted for review and inclusion in Ethereum’s next system-wide upgrade or hard fork which has been dubbed, Istanbul. […]
2019-6-21 22:18 | |
|
|
Yet another journey to launch a bitcoin exchange-traded fund (ETF) has begun. According to a published notice, the U. S. Securities and Exchange Commission (SEC) has begun reviewing a proposed rule change for a bitcoin ETF filed by NYSE Arca and Bitwise.
2019-2-18 18:46 | |
|
|
GRAFT Blockchain project team has published an RFC looking for comments on it’s proof-of-stake mechanism implementation including the stake locking mechanism. Requests for Comments (RFC) are often used by transparent engineering initiatives to solicit feedback from the community at large about a planned design.
2018-12-15 05:08 | |
|
|
Amun AG, a startup in Zug, Switzerland, has received a license from Swiss authorities to offer a new cryptocurrency exchange-traded product (ETP). An ETP is a blanket term to denote a security that derives its price from an underlying asset (e.
2018-11-20 02:50 | |
|
|
The digital currency ETF is a big part of the debate in a recent Bloomberg interview which had JP Morgan’s Asset Management Head of International ETFs, Bryson Lake on the panel. The interview looked at how JP Morgan believes in the latest mover advantage in terms of the digital currency market and ETFs.
2018-10-12 12:00 | |
|
|
Japan’s financial regulator has recently unveiled the current state of the crypto regulations in the country. Three crypto operators are currently being reviewed. With 160 companies wanting to enter the space, the regulator plans to add more personnel to help review new applicants.
2018-9-17 09:12 | |
|
|
The United States Securities and Exchange Commission (SEC) is in no hurry to review the pile of Bitcoin ETF filings it has been accumulating over the past year. Not three weeks since postponing its decision on five other Bitcoin ETFs, the SEC has indicated in a public statement that it will be delaying its decision to approve or reject SolidX Bitcoin Shares until late September.
2018-8-8 17:15 | |
|
|
The United States Securities and Exchange Commission (SEC) has rejected the Winklevosses’ latest attempt to list a bitcoin ETF. After having a proposal rejected last year, the Gemini exchange founders had hoped to secure their Winklevoss Bitcoin Trust on BATS Global Market’s BZX stock exchange with this latest attempt.
2018-7-27 02:19 | |
|
|
“We have nothing to hide,” says Tory Reiss, VP of corporate development at TrustToken. Like the market’s most popular stablecoin, Tether, TrustToken's TrueUSD is fiat-collateralized.
2018-7-26 18:55 | |
|
|
The U. S. Securities and Exchange Commission (SEC) has postponed the review of Bitcoin ETFs proposed by investment firm Direxion Asset Management, as it needs more time to study the proposal before reaching a final decision.
2018-7-26 23:43 | |
|
|
A report from Kommersant, a local Russian outlet reveals that Anatoly Aksakov, the head of Russia’s State Duma Financial Market Committee explained that crucial changes will be made in the Country’s draft laws which is meant to regulate Cryptocurrency in Russia.
2018-6-16 11:45 | |
|
|
Coinspeaker PFE Up 4%, BNTX Up 10%, U. S. Government to Pay $1. 95B to Pfizer, BioNTech for COVID-19 VaccineThe U. S. Government has signed a $1. 95 billion deal with Pfizer and BioNTech for their COVID-19 vaccine.